Omega Fund IV, L.P. is Director & 10% Owner at Replimune Group, Inc. (REPL). They have made 1 open-market trade across 1 company since 2021, most recently 2021-09-17.
CIK 0001528382
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| REPL | 4,908,245 | $53.4M |
Shares reported on the most recent Form 4, priced at the 2021-09-20 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| REPL | SELL | 2021-09-16 | 2021-09-20 | $32.99 | $6.6M | -6.5% | -8.4% | -16.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.